Lyall R A, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey M I, Leigh P N, Moxham J
Respiratory Muscle Laboratory, Department of Respiratory Medicine, Guy's, King's, and St. Thomas' School of Medicine, London, United Kingdom.
Neurology. 2001 Jul 10;57(1):153-6. doi: 10.1212/wnl.57.1.153.
Noninvasive positive pressure ventilation prolongs survival in ALS but its effect on quality of life is unknown. The authors prospectively studied quality of life using the SF-36 questionnaire in a cohort of 16 ventilated patients with ALS. Noninvasive positive pressure ventilation improved scores in the "Vitality" domain by as much as 25%, for periods of up to 15 months, despite disease progression. Noninvasive positive pressure ventilation did not cause reduced quality of life, as any fall in scores in the ventilated group were comparable to those seen in a control group. In conclusion, noninvasive positive pressure ventilation enhances quality of life when used to treat sleep-disordered breathing in patients with ALS.
无创正压通气可延长肌萎缩侧索硬化症(ALS)患者的生存期,但其对生活质量的影响尚不清楚。作者使用SF-36问卷对16例接受通气治疗的ALS患者进行了前瞻性生活质量研究。尽管疾病在进展,但无创正压通气在长达15个月的时间里使“活力”领域的得分提高了25%。无创正压通气并未导致生活质量下降,因为通气组的任何得分下降与对照组所见相当。总之,无创正压通气用于治疗ALS患者的睡眠呼吸障碍时可提高生活质量。